» Articles » PMID: 22441322

Health Status Assessment in Routine Clinical Practice: the Chronic Obstructive Pulmonary Disease Assessment Test Score in Outpatients

Overview
Journal Respiration
Publisher Karger
Specialty Pulmonary Medicine
Date 2012 Mar 24
PMID 22441322
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The chronic obstructive pulmonary disease (COPD) assessment test (CAT) is a simple, self-completion questionnaire developed to measure health status in patients with COPD, which is potentially suitable for routine clinical use.

Objectives: The purpose of this study was to establish the determinants of the CAT score in routine clinical practice.

Methods: Patients attending the clinic completed the CAT score before being seen. Clinical data, including, where available, plethysmographic lung volumes, transfer factor and arterial blood gas analysis, were recorded on a pro forma in the clinic.

Results: In 224 patients (36% female), mean forced expiratory volume in 1 s (FEV₁) was 40.1% (17.9) of predicted (%pred); CAT score was associated with exacerbation frequency [0-1/year 20.1 (7.6); 2-4/year 23.5 (7.8); >4/year 28.5 (7.3), p < 0.0001; 41/40/19% in each category] and with Medical Research Council (MRC) dyspnoea score (r² = 0.26, p < 0.0001) rising approximately 4 points with each grade. FEV(1) %pred had only a weak influence. Using stepwise regression, CAT score = 2.48 + 4.12 [MRC (1-5) dyspnoea score] + 0.08 (FEV(1) %pred) + 1.06 (exacerbation rate/year)] (r² = 0.36, p < 0.0001). The CAT score was higher in patients (n = 54) with daily sputum production [25.9 (7.5) vs. 22.2 (8.2); p = 0.004]. Detailed lung function (plethysmography and gas transfer) was available in 151 patients but had little influence on the CAT score.

Conclusion: The CAT score is associated with clinically important variables in patients with COPD and enables health status measurement to be performed in routine clinical practice.

Citing Articles

Singing for lung health in COPD: a multicentre randomised controlled trial of online delivery.

Philip K, Buttery S, Bowen S, Lewis A, Jeffery E, Alghamdi S BMJ Open Respir Res. 2024; 11(1).

PMID: 38697677 PMC: 11086531. DOI: 10.1136/bmjresp-2024-002365.


High burden of symptoms reported among patients diagnosed with chronic obstructive pulmonary disease (COPD) in Greenland after introducing the COPD Assessment Test in clinical practice.

Nielsen M, Lynge A, Pedersen M Int J Circumpolar Health. 2023; 82(1):2220476.

PMID: 37267504 PMC: 10240970. DOI: 10.1080/22423982.2023.2220476.


COPD exacerbations and patient-reported outcomes according to post-bronchodilator FEV - a post-hoc analysis of pooled data.

Chai C, Ng D, Bt Mos S, Ibrahim M, Tan S, Pang Y BMC Pulm Med. 2023; 23(1):150.

PMID: 37118725 PMC: 10148499. DOI: 10.1186/s12890-023-02436-1.


Lung volume reduction surgery endobronchial valves: a randomised controlled trial.

Buttery S, Banya W, Bilancia R, Boyd E, Buckley J, Greening N Eur Respir J. 2023; 61(4).

PMID: 36796833 PMC: 10133584. DOI: 10.1183/13993003.02063-2022.


Change in individual chronic obstructive pulmonary disease assessment test item scores after short-term bronchodilator therapy and its impact on exacerbation in treatment-naïve patients with chronic obstructive pulmonary disease.

Kim B, Shin S, Gil H, Zo S, Im Y, Song J Ther Adv Chronic Dis. 2022; 13:20406223221114235.

PMID: 35924010 PMC: 9340891. DOI: 10.1177/20406223221114235.